| | Term | Pathway | Genes | P value |
| | hsa05200 | Pathways in cancer | JUN, NOS2, MMP2, PTGER3, PTGS2, MMP9, EGFR, PGF, IGF1R, VEGFA, AR, PIK3CA, MDM2, AGTR1, AKT1, RARB, PPARG, BCL2L1, MAPK3 | 4.30E − 11 | | hsa05205 | Proteoglycans in cancer | SRC, MMP2, ESR1, TNF, MMP9, EGFR, IGF1R, VEGFA, PIK3CA, MDM2, KDR, AKT1, MAPK3 | 7.30E − 09 | | hsa04014 | Ras signaling pathway | PIK3CA, PLA2G1B, KDR, PLA2G4A, AKT1, EGFR, PGF, BCL2L1, IGF1R, MAPK3, VEGFA | 2.62E − 06 | | hsa04151 | PI3K-Akt signaling pathway | PIK3CA, MDM2, KDR, AKT1, EGFR, PGF, BCL2L1, IGF1R, MCL1, MAPK3, VEGFA | 1.05E − 04 | | hsa04510 | Focal adhesion | JUN, PIK3CA, SRC, KDR, AKT1, EGFR, PGF, IGF1R, MAPK3, VEGFA | 9.89E − 06 | | hsa04015 | Rap1 signaling pathway | PIK3CA, CNR1, SRC, KDR, AKT1, EGFR, PGF, IGF1R, MAPK3, VEGFA | 1.16E − 05 | | hsa04915 | Estrogen signaling pathway | JUN, PIK3CA, SRC, MMP2, AKT1, ESR1, MMP9, EGFR, MAPK3 | 3.25E − 07 | | hsa04370 | VEGF signaling pathway | PIK3CA, SRC, KDR, PLA2G4A, AKT1, PTGS2, MAPK3, VEGFA | 1.68E − 07 | | hsa04066 | HIF-1 signaling pathway | PIK3CA, NOS2, SERPINE1, AKT1, EGFR, IGF1R, MAPK3, VEGFA | 3.82E − 06 | | hsa05142 | Chagas disease (American trypanosomiasis) | JUN, ACE, PIK3CA, NOS2, SERPINE1, AKT1, TNF, MAPK3 | 6.52E − 06 | | hsa04668 | TNF signaling pathway | JUN, PIK3CA, MMP3, AKT1, PTGS2, TNF, MMP9, MAPK3 | 7.88E − 06 | | hsa05202 | Transcriptional misregulation in cancer | IGFBP3, MMP3, MDM2, PPARG, MPO, MMP9, BCL2L1, IGF1R | 1.39E − 04 | | hsa05219 | Bladder cancer | SRC, MMP2, MDM2, MMP9, EGFR, MAPK3, VEGFA | 3.13E − 07 | | hsa05215 | Prostate cancer | AR, PIK3CA, MDM2, AKT1, EGFR, IGF1R, MAPK3 | 2.94E − 05 | | hsa05161 | Hepatitis B | JUN, PIK3CA, SRC, AKT1, TNF, MMP9, MAPK3 | 4.68E − 04 | | hsa05164 | Influenza A | JUN, PIK3CA, NLRP3, AKT1, PLG, TNF, MAPK3 | 0.001220965 | | hsa04024 | cAMP signaling pathway | JUN, PIK3CA, PTGER3, PDE4A, AKT1, PPARA, MAPK3 | 0.002361912 | | hsa05206 | MicroRNAs in cancer | ABCB1, MDM2, PTGS2, MMP9, EGFR, MCL1, VEGFA | 0.013841455 | | hsa05212 | Pancreatic cancer | PIK3CA, AKT1, EGFR, BCL2L1, MAPK3, VEGFA | 8.07E − 05 | | hsa05214 | Glioma | PIK3CA, MDM2, AKT1, EGFR, IGF1R, MAPK3 | 8.07E − 05 |
|
|
